FAKTOR OPTIONSSCHEIN - MERCK & CO. | Market Closed - Boerse Frankfurt Warrants 13:35:29 2024-06-05 EDT | ||
| 3.71 EUR | -2.62% |
|
| Current month | -9.95% | ||
| 1 month | -6.31% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-05 | 3.71 | -2.62% |
| 24-06-04 | 3.81 | -1.04% |
| 24-06-03 | 3.85 | -6.55% |
| 24-05-31 | 4.12 | +5.64% |
| 24-05-30 | 3.9 | -4.41% |
Real-time Boerse Frankfurt Warrants
Last update June 05, 2024 at 01:35 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | UBS |
| WKN | UM0K9D |
| ISIN | DE000UM0K9D0 |
| Date issued | 2024-01-25 |
| Strike | 171.6 $ |
| Maturity | Unlimited |
| Parity | 10.35 : 1 |
| Emission price | 5.02 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.01 € |
|---|---|
| Lowest since issue | 3.47 € |
| Spread | 0.05 € |
| Spread % | 1.34% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.4
USD
Average target price
142.7
USD
Spread / Average Target
+10.22%
- Stock Market
- Certificates
- Certificat
